Prashant R. Murumkar

Author

Maharaja Sayajirao University of Baroda ORCID

Also Known As

Murumkar, Prashant, Murumkar, Prashant R., P. Murumkar, P. R. Murumkar, P.R. Murumkar, PR Murumkar, Prashant Murumkar, Prashant R Murumkar, Prashant R. Murumkar, Prashant Revan Murumkar

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

Maharaja Sayajirao University of Baroda Sardar Patel University Institute of Nuclear Medicine & Allied Sciences University of Jammu Universidad de La Laguna

About

Prashant R. Murumkar is an author at Maharaja Sayajirao University of Baroda specializing in drug discovery, medicine, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	15	496
2	Biochemistry	10	10	361
3	Natural Sciences	9	9	233
4	Chemical Biology	4	4	105
5	Biomolecular Engineering	1	1	29

Prashant R. Murumkar

Publications

830

Citations

H-Index

Page 1

	Year	Citations
Overview of the Development of DprE1 Inhibitors for Combating the Menace of Tuberculosis Rupesh V. Chikhale, Mahesh A. Barmade, Prashant R. Murumkar, Journal of Medicinal Chemistry Drug LibraryTuberculosis PreventionImmunologyPharmacotherapyAntimicrobial Chemotherapy	2018	140
Benzylpiperidine-Linked Diarylthiazoles as Potential Anti-Alzheimer’s Agents: Synthesis and Biological Evaluation Mahesh Mohan Shidore, Jatin Machhi, Kaushik Shingala, Journal of Medicinal Chemistry	2016	107
Dihydropyrimidinone-isatin hybrids as novel non-nucleoside HIV-1 reverse transcriptase inhibitors Titiksh L. Devale, Jignesh Parikh, Pankaj B. Miniyar, Bioorganic Chemistry MedicineAntiviral Drug DevelopmentResistance Mutation (Virology)Dihydropyrimidinone-isatin HybridsHiv	2017	52
Development of predictive pharmacophore model for in silico screening, and 3D QSAR CoMFA and CoMSIA studies for lead optimization, for designing of potent tumor necrosis factor alpha converting enzyme inhibitors Prashant R. Murumkar, Vishal P. Zambre, Mange Ram Yadav Journal of Computer-Aided Molecular Design Medicinal ChemistryDrug TargetBiochemistryDrug DesignMedicine	2010	45
Novel Multitarget Directed Triazinoindole Derivatives as Anti-Alzheimer Agents Dushyant V. Patel, Nirav R. Patel, Ashish M. Kanhed, ACS Chemical Neuroscience	2019	42
3D‐Quantitative Structure–Activity Relationship Studies on Benzothiadiazepine Hydroxamates as Inhibitors of Tumor Necrosis Factor‐α Converting Enzyme Prashant R. Murumkar, Rajani Giridhar, Mange Ram Yadav Chemical Biology & Drug Design	2008	36
Studies on novel 2-imidazolidinones and tetrahydropyrimidin-2(1H)-ones as potential TACE inhibitors: Design, synthesis, molecular modeling, and preliminary biological evaluation Shirshendu DasGupta, Prashant R. Murumkar, Rajani Giridhar, Bioorganic & Medicinal Chemistry Combinatorial ChemistryMedicinal ChemistryBioorganic ChemistryPreliminary Biological EvaluationBiochemistry	2009	36
Development of Predictive 3D‐QSAR CoMFA and CoMSIA Models for β‐aminohydroxamic Acid‐Derived Tumor Necrosis Factor‐α Converting Enzyme Inhibitors Prashant R. Murumkar, Shirshendu Das Gupta, Vishal P. Zambre, Chemical Biology & Drug Design	2008	34
Development of highly predictive 3D-QSAR CoMSIA models for anthraquinone and acridone derivatives as telomerase inhibitors targeting G-quadruplex DNA telomere Vishal P. Zambre, Prashant R. Murumkar, Rajani Giridhar, Journal of Molecular Graphics and Modelling Medicinal ChemistryG-quadruplex DnaNatural SciencesRational Drug DesignMolecular Biology	2010	29
Structural Investigations of Acridine Derivatives by CoMFA and CoMSIA Reveal Novel Insight into Their Structures toward DNA G-Quadruplex Mediated Telomerase Inhibition and Offer a Highly Predictive 3D-Model for Substituted Acridines Vishal P. Zambre, Prashant R. Murumkar, Rajani Giridhar, Journal of Chemical Information and Modeling Combinatorial ChemistryBioorganic ChemistryHighly Predictive 3D-modelMolecular BiologyClick Chemistry	2009	29

Page 1